Similarly, targeting the novel oncogene Aminoacyl-tRNA synthetase-interacting multifunctional protein 1 (AIMP1) with siAIMP1-loaded exosomes derived from OCI-MY5 cells could inhibit MM growth and bone lesion formation [116]. Here, AIMP1 is linked to Miyoshi myopathy.